Industrial Microbiology INDM 4005 Lecture 1 090204 - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

Industrial Microbiology INDM 4005 Lecture 1 090204

Description:

Understand the principles of bioprocessing which include bioreactor design and ... Biomass Supernatant. Product Purification. Process Design. Inoculum ... – PowerPoint PPT presentation

Number of Views:2163
Avg rating:3.0/5.0
Slides: 31
Provided by: ajmclo
Category:

less

Transcript and Presenter's Notes

Title: Industrial Microbiology INDM 4005 Lecture 1 090204


1
Industrial MicrobiologyINDM 4005Lecture
109/02/04
2
Overall Course aim
  • Cover the basic science of bioprocessing
  • Integrated approach to
  • - Microbial physiology
  • - Fermentation technology
  • - Bioprocess engineering

3
Learning Outcomes
  • Understand the principles of bioprocessing which
    include bioreactor design and process
    optimisation
  • Apply these principles to unit operations in the
    fermentation, brewing and antibiotic industries

4
(No Transcript)
5
Process Design
UPSTREAM Stock culture Raw
material Seed Fermenter Shake Medium
preparation Flask Sterilisation
Bioreactor
DOWNSTREAM
Separation Biomass Supernatant
Product Purification
Inoculum
6
1. MANAGEMENT OF MICROBIAL PROCESSES / QUALITY
ASSURANCE
  • Overview
  • ? Principles of GMP
  • ? Process design / optimisation
  • ? Economics

7
DEVELOPMENT OF A MICROBIAL PROCESS
  • The development of a new fermentation product is
    influenced by many factors including
  • the market
  • the regulatory environment
  • the current level of scientific knowledge

8
DEVELOPMENT OF MICROBIAL PROCESSES(Hulse, 2004)
Trends in Food Science Technology 15 p3-18
  • Penicillin 1928
  • Monoclonal antibodies 1970s
  • Recombinant DNA technology 1980s
  • The Future 2010 ???

9
QUALITY ASSURANCE
  • Any product released in the marketplace must
    conform to quality procedures
  • - National and International regulatory
    requirements
  • - Manufacturers guideline requirements
  • - In house company standards
  • Quality Assurance is defined as a program that is
    intended, by its actions, to guarantee a standard
    level of quality

10
QUALITY ASSURANCE
Product Product Product Research Manu
facture Design Development Good
Manufacturing Quality Practices
Control
11
GOOD MANUFACTURING PRACTICE
  • GMP - is used internationally to describe a set
    of principles and procedures which, when followed
    by manufacturers of therapeutic goods, helps
    ensure that the products manufactured will have
    the required quality.
  • A basic tenet of GMP is that quality cannot be
    tested into a batch of product but must be built
    into each batch of product during all stages of
    the manufacturing process.

12
QUALITY CONTROL
  • A system by which a desired standard of quality
    in a product or process is maintained.
  • Quality control usually requires feeding back
    information about measured defects to further
    improvements of the process.
  • Is concerned with sampling, specifications,
    testing, documentation

13
MANAGEMENT AND GOOD MANUFACTURING
  • Requires highest standards of process and product
    quality assurance.
  • Recombinant products, cell culture products,
    drugs etc should generally possess attributes of
    purity, safety, potency, efficacy, consistency
    and stability.
  • Determination of existing or potential risk
    factors associated with the process or product
    important in assurance of safety of product,
    process operators etc.

14
  • Reference
  • For Introduction to Product development ,
    regulation and safety see Michael J. Waites,
    Industrial Microbiology an Introduction, Chp 8
    p124.

15
1.1 MANAGEMENT AND GOOD MANUFACTURING
  • Good Manufacturing Practice (GMP) pertains to all
    bioprocessing.
  • Definition
  • Term for technical procedures undertaken under
    recognised standards to ensure that products are
    consistently produced and controlled and that
    these products are appropriate to their intended
    use and product specification
  • Relates to
  • ? consumer
  • ? worker
  • ? product safety

16
1.1.1 RISK FACTORS
  • Must be clearly identified
  • acceptable processing
  • analytical methods and practices
  • developed as a standardised process
    validation
  • To minimise risk, manufacturing facilities and
    plant operations should conform with requirements
    for GMP, for example
  • - Compartmentation of operations e.g.
    clean-room
  • - Design of containment areas- Water quality
  • - Design of Cell cultivation facility
  • - Definition of work practices in different areas
  • - Details of personnel allowed access to each
    area
  • - Protocols for maintenance and cleaning
  • - Protocols for staff training
  • - Definitions of personnel roles - who is
    responsible for what ??
  • - Definition of practices for record maintenance

17
1.1.2 IMPLEMENTATION OF GMP
  • Implications for all facets of bioprocess
  • ? Microorganism / biological system
  • ? Nature of processing steps used
  • ? Equipment design
  • ? Raw materials
  • ? Operator training
  • ? Analytical / laboratory procedures
  • ? Product specification
  • ? Product cost

18
1.1.2 IMPLEMENTATION OF GMP
  • IDENTIFICATION OF MAJOR SOURCES OF ERROR /
    CRITICAL POINTS
  • 1. Materials - variation in specification
  • 2. Equipment / facilities - variable operating
  • 3. Procedures - lack of clarity / specificity
  • 4. Personnel - lack of training / motivation
  • MINIMIZE ERRORS / DEVIATIONS BY PROCESS
    VALIDATION
  • Challenge to the process to determine whether
    pre-selected process variables are under control.
  • To ensure high uniformity and reproducibility in
    process consistency and high quality of product.

19
1.1.3. PROCESS VALIDATION -organisation
  • Written documentation
  • Manufacturing parameters
  • Testing parameters
  • In-process control
  • Final product testing

20
1.1.4. DESIGN OF FACILITY
  • TASK 1
  • Identify major objectives relating to each unit
    operation. Identify critical control points
    (CCP) in inoculum preparation, media preparation,
    fermentation step, product recovery/purification
    and in managing asepsis.
  • CASE STUDY -Design of facility, for example, for
    production of extracellular soluble vaccine by a
    pathogenic organism
  • Inoculum
  • Fermenter design
  • Cell recovery
  • Finishing operations -Purification and packaging
  • Asepsis / Sterility

21
1.1.5. DIRECTIVES LEGISLATION
  • Many manufacturers (e.g. Pharmaceutical, Food
    etc.) must conform to requirements /
    recommendations laid down
  • ?EC, EU
  • ?World Health Organisation
  • ?US Food Drugs Administration
  • ?Individual National Authorities
  • See library for Directives Covers wide range of
    areas
  • - Organisation and personnel - Buildings
  • - Facilities and equipment - Control of
    components
  • - Containers and closures - Process control
  • - Packaging and labelling - Holding and
    distribution
  • - Laboratory controls - Records of reports

22
1.2. PROCESS DESIGN i.e. INDUSTRIAL FERMENTATION
  • 1.2.1. DESIGN PARAMETERS RELATING TO
  • ? MICROORGANISM
  • ? RAW MATERIALS
  • ? PROCESS
  • ? PRODUCT
  • see additional sheet for critical control points
  • 1.2.2. Relate parameters to SPECIFIC INDUSTRIES
    already studied.

23
  • CASE-STUDY
  • Identify relevant parameters (using above
    headings) FROM ONE of the following industries
  • Brewing
  • Pharmaceuticals
  • Organic acids
  • Fermented Foods
  • Enzymes
  • Waste treatment /environmental

24
1.3. FERMENTATION ECONOMICS
  • OBJECTIVE - yield a product at a competitive
    price
  • 1.3.1. BASIC OBJECTIVES.
  • ? Capital investment a minimum
  • ? Inexpensive raw materials
  • ? High yielding strain of microorganism
  • ? Labour saving and automation
  • ? Batch Production cycles as short as possible
  • ? Recovery and purification - simple rapid
  • ? Minimise waste streams
  • ? Heat and power used efficiently
  • ? Space requirement minimised

25
1.3.2. MAJOR AREAS OF COST MINIMISATION
  • 1. Isolation and handling of microorganism
  • 2. Plant and equipment
  • 3. Media
  • 4. Air sterilisation
  • 5. Heating and cooling
  • 6. Aeration and agitation
  • 7. Recovery cost
  • 8. Process time and duration
  • 9. Prevention of contamination
  • See Stanbury and Whitaker p.231

26
1.3.3. Calculation of productivity, cost, profit,
optimum production cycle.
  • 1.3.3.1 PRODUCTIVITY
  • In a batch process productivity must be
    calculated for the complete cycle. The total time
    (t) for a fermentation may be calculated
  • t 1/?m? (ln Xf/Xo ) tT tL tD
  • where ?m maximum specific growth rate
  • Xo initial cell conc.
  • Xf final cell conc.
  • tT turn-around time (washing, filling,
    sterilisation, etc)
  • tD delay time until inoculation
  • tL lag time after inoculation

27
PRODUCTIVITY
  • The overall productivity P is given by P Xf/ t
  • It will be possible from this equation to
    determine the effect of process changes on the
    overall productivity.
  • For example, a larger initial inoculum would
    increase Xo and shorten the process time.
  • Actively growing inocula would reduce the lag
    time (tL)

28
1.3.3.2 OPTIMUM TIME FOR HARVESTING
  • CASE STUDY
  • Identify the
  • (a) optimum harvest time
  • (b) productivity of a fermentation cycle.
  • SEE CHAPTER 12

29
Effect of running time on productivity and cost -
optimum time of harvesting
In Stanbury and Whitaker
30
Conclusion
  • Understand the importance of being able to manage
    microbial processes
  • What is quality assurance?
  • How to implement GMP
  • Fermentation economics
  • How to calculate productivity
Write a Comment
User Comments (0)
About PowerShow.com